COMPANY PROFILE

Pathology Watch

Explore full profile

Delivers an intuitive and easy-to-implement digital pathology solution for dermatologists

Salt Lake City, United StatesFounded 2018Biotech & Life Sciences

Valuation $100–250M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Pathology Watch

PathologyWatch is a leading provider of digital dermatopathology services, combining expert dermatopathology with cutting-edge digital technology. The company primarily serves dermatologists, offering a comprehensive suite of services including digital pathology, telepathology, and locum tenens support. Operating in the healthcare and medical diagnostics market, PathologyWatch leverages its proprietary digital platform to improve diagnostic accuracy and operational efficiency for its clients. The business model is based on providing subscription-based access to its digital pathology services, as well as offering expert consultations and diagnostic support. Revenue is generated through service fees and subscription plans tailored to the needs of dermatology practices. PathologyWatch's innovative solutions have been shown to save significant time for medical staff and improve overall practice efficiency.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2018
Headquarters: Salt Lake City, United States
Employees: 57
Open positions: None listed
Dealroom signal: 68.8/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Nov 2023	$150M	$150M	Sonic Healthcare	↗
OtherOther financing	Mar 2023	$0	—	Alchemist Accelerator	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Pathology Watch website traffic

Latest recorded traffic for Pathology Watch is 2.5K monthly website visits, up 78.6% over the last three months. Pathology Watch's team declined 8.1% over the past year.

Latest monthly visits2.5K 3-month web change+78.6% 1-year team growth-8.1%

Monthly website visitsApr 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PLPLTTECHEngages in the R&D of single-cell precision research solutions	Hangzhou, China	Operational	—	$1.4M	—
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
WMWeiyan MedicalA provider of infection precision medicine products and services	Dongcheng District, China	Operational
REReplayReprogramming biology by writing and delivering big DNA	San Diego, United States	Acquired
NPNaegis PharmaceuticalsInnovative small molecule therapies targeting inflammatory mediators for serious eye diseases	Vancouver, Canada	Operational
ACActiTrexxA safe and efficient treatment option for transplanted patients providing substantial improvement of survival rate and quality of life	Mainz, Germany	Operational
RBRage BiotechRAGE Biotech is developing new approaches to modulate the receptor for advanced glycation end-products (RAGE), an important target in chronic inflammation	Melbourne, Australia	Operational
CTCytovia TherapeuticsDevelops transformational cancer immunotherapies and addresses several unmet medical needs for cancer prevention	Aventura, United States	Operational